By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Magellan Biosciences today announced a deal with Bruker combining their technologies for microbial identification.

Under the terms of the deal, Magellan will develop and test an integrated cross-platform software interface for microbial identification gathered on Bruker's MALDI Biotyper mass spectrometer-based platform combined with results from Magellan's Trek-brand Sensititre susceptibility-testing platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.